Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates.
about
The emergence of Lyme diseaseDiagnosis of lyme borreliosis.Two-Tiered Antibody Testing for Lyme Disease With Use of 2 Enzyme Immunoassays, a Whole-Cell Sonicate Enzyme Immunoassay Followed by a VlsE C6 Peptide Enzyme ImmunoassayProspective study of serologic tests for lyme disease.Epidemiology and diagnosis of Lyme borreliosisSerologic evaluation of patients from Missouri with erythema migrans-like skin lesions with the C6 Lyme testvls Antigenic Variation Systems of Lyme Disease Borrelia: Eluding Host Immunity through both Random, Segmental Gene Conversion and Framework HeterogeneityThe Past, Present, and (Possible) Future of Serologic Testing for Lyme DiseaseThe Accuracy of Diagnostic Tests for Lyme Disease in Humans, A Systematic Review and Meta-Analysis of North American ResearchCurrent Guidelines, Common Clinical Pitfalls, and Future Directions for Laboratory Diagnosis of Lyme Disease, United States.Use of Peptide library screening to detect a previously unknown linear diagnostic epitope: proof of principle by use of lyme disease sera.Identification of Borrelia burgdorferi ribosomal protein L25 by the phage surface display method and evaluation of the protein's value for serodiagnosisApplication of Bayesian decision-making to laboratory testing for Lyme disease and comparison with testing for HIVIdentification of OppA2 linear epitopes as serodiagnostic markers for Lyme disease.The borrelial fibronectin-binding protein RevA is an early antigen of human Lyme disease.A Bayesian spatio-temporal model for forecasting the prevalence of antibodies to Borrelia burgdorferi, causative agent of Lyme disease, in domestic dogs within the contiguous United StatesWhen a patient suspected with juvenile idiopathic arthritis turns out to be diagnosed with an infectious disease - a review of Lyme arthritis in childrenBorrelia burgdorferi-specific IgA in Lyme Disease.Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease.BBK07 immunodominant peptides as serodiagnostic markers of Lyme disease.A comparison of serologic tests for the detection of serum antibodies to whole-cell and recombinant Borrelia burgdorferi antigens in cattle.Borrelia miyamotoi sensu lato seroreactivity and seroprevalence in the northeastern United States.Rapid, simple, quantitative, and highly sensitive antibody detection for lyme diseaseImprovement of Lyme borreliosis serodiagnosis by a newly developed recombinant immunoglobulin G (IgG) and IgM line immunoblot assay and addition of VlsE and DbpA homologues.A decline in C6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated Lyme Borreliosis.Collection and characterization of samples for establishment of a serum repository for lyme disease diagnostic test development and evaluation.A twist on Lyme: the challenge of diagnosing European Lyme neuroborreliosis.Outer surface protein C peptide derived from Borrelia burgdorferi sensu stricto as a target for serodiagnosis of early lyme diseaseA decrease in the immunoglobulin G antibody response against the VlsE protein of Borrelia burgdorferi sensu lato correlates with the resolution of clinical signs in antibiotic-treated patients with early Lyme disease.Microbiological and serological diagnosis of Lyme borreliosis.Decorin binding proteins A and B in the serodiagnosis of Lyme disease in North America.Inferring epitopes of a polymorphic antigen amidst broadly cross-reactive antibodies using protein microarrays: a study of OspC proteins of Borrelia burgdorferiMultiplex immunoassay for Lyme disease using VlsE1-IgG and pepC10-IgM antibodies: improving test performance through bioinformatics.Antibody profiling of Borrelia burgdorferi infection in horsesBorrelia burgdorferi spirochetes that harbor only a portion of the lp28-1 plasmid elicit antibody responses detectable with the C6 test for Lyme diseaseLaboratory diagnosis of Lyme disease: advances and challengesSerum antibodies to whole-cell and recombinant antigens of Borrelia burgdorferi in cottontail rabbits.Epitope length, genospecies dependency, and serum panel effect in the IR6 enzyme-linked immunosorbent assay for detection of antibodies to Borrelia burgdorferi.'Nothing is permanent but change'- antigenic variation in persistent bacterial pathogensDominant epitopes of the C6 diagnostic peptide of Borrelia burgdorferi are largely inaccessible to antibody on the parent VlsE molecule
P2860
Q22241895-FCD56427-BFC1-4678-9181-85EDF05A64C5Q22242237-BA3EC64D-3EC0-4366-922D-1E13E0779754Q22242917-2D8EFDAB-4028-4A96-A7A9-6E0CC7FC4AFEQ22242954-4DABE87D-A57D-4981-A971-E81FAEE0E766Q22248045-B5DDEB10-7591-452C-B385-FF4D994B939BQ24678470-82F09EF5-B582-444C-B399-735995C4A47CQ26829575-240C6FB3-AAF8-46F2-8878-AEEFFCC1C39DQ28075680-92D82C57-0404-4624-A5E9-E04A03075880Q28354112-B3C155EF-C78D-4482-A365-C48B42A5738AQ30357899-405E1C4E-9DA6-4320-843D-0C8A6BECFF70Q30448319-B9CCCC49-42C9-4278-889C-3165B380E9C4Q33259362-5A2CEBAD-E025-4FB1-9079-599E46183CE4Q33565276-5B218F2D-FF11-47BB-828D-324733E56FD4Q33601926-E2C95F6D-57AE-4C23-83EA-57E58AB39C1BQ33627104-A2609CDE-BFD6-4326-8D6E-913117FB1C0BQ33637307-9A11751B-8A21-4A3C-886A-424F5D15992FQ33651558-1490C2F3-7206-43F8-964D-0CBF6325F34FQ33715901-DE0FCA34-F29F-42C0-B034-29562E27B58FQ33738269-600FB638-E0C4-440B-B517-B1C9F79780A2Q33777952-FC13DDAE-0593-4D7A-BDA2-927C5029202CQ33778130-9B6C9086-868E-4071-B3F3-9F10C949042BQ33816370-A20AC962-C36C-4C47-8370-088A731A76D0Q33909157-86FE3CA7-5C14-415F-B1AC-38338374ED8DQ34041878-059F099C-5816-4CFD-A0A9-11D059A43E0FQ34045483-237DE358-7F34-48E5-B03B-8D6F920CF928Q34298182-635D4B0D-3A07-4434-A3C9-C8042DB9C19BQ34487621-E9DE4A47-A9D3-4F88-B158-B225848B7210Q34568050-BD88BA90-340A-4749-9DBA-2933D27781DAQ34601381-F6359CB9-CFD6-426C-8B8B-6EA9DA5B7D65Q34608068-7453766D-5E80-4585-AD47-B39D826A0E47Q34701380-B1EEAEBE-D334-4B4D-AC43-1CF63036FC87Q34797227-1AD459F6-3B09-47AC-B2A7-C55CED40DE29Q35066161-912C1208-E6AE-4684-8C79-E8E94818A973Q35191085-ADD2BA14-575D-49B2-BE5D-274589EFA6E1Q35635857-85B34617-5039-49AA-8BB9-6CE41BCE86E8Q35638551-87B78F65-FF45-4A1B-987A-8E09B24B6181Q35681719-582565B1-FFDE-4A9F-8109-5413C0470829Q35946915-BEBC2D76-6E94-4504-A6D7-C819FA48BACCQ35968220-2E44FAE8-1C0C-4572-9C57-B909288A1873Q36097158-D7A5BE16-46D6-487A-B225-438C483D4CEF
P2860
Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Serodiagnosis of Lyme disease ...... ting using whole-cell lysates.
@ast
Serodiagnosis of Lyme disease ...... ting using whole-cell lysates.
@en
Serodiagnosis of Lyme disease ...... ting using whole-cell lysates.
@nl
type
label
Serodiagnosis of Lyme disease ...... ting using whole-cell lysates.
@ast
Serodiagnosis of Lyme disease ...... ting using whole-cell lysates.
@en
Serodiagnosis of Lyme disease ...... ting using whole-cell lysates.
@nl
prefLabel
Serodiagnosis of Lyme disease ...... ting using whole-cell lysates.
@ast
Serodiagnosis of Lyme disease ...... ting using whole-cell lysates.
@en
Serodiagnosis of Lyme disease ...... ting using whole-cell lysates.
@nl
P2093
P356
P1476
Serodiagnosis of Lyme disease ...... ting using whole-cell lysates.
@en
P2093
Adriana R Marques
Allen C Steere
Barbara J B Johnson
Gary P Wormser
Mario T Philipp
Martin E Schriefer
Rendi Murphree Bacon
Robert D Gilmore
P304
P356
10.1086/374395
P407
P577
2003-04-02T00:00:00Z